Eli Lilly Claims Experimental Drug Protects Covid-19 Patients
A so-called monoclonal antibody lowered levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts.
Source: NYT Health - Category: Consumer Health News Authors: Gina Kolata Tags: Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Antibodies Clinical Trials Eli Lilly and Company National Institutes of Health United States Source Type: news
More News: Clinical Trials | Coronavirus | COVID-19 | Health | National Institutes of Health (NIH) | USA Health